Skip to content

Clinical trials

Completed Phase 2 Thyroid Neoplasms trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Thyroid Neoplasms Phase: Phase 2 Status: Completed Clear all

72 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20012
20033
20048
20055
20066
20075
20084
20094
20104
20111
20123
20136
20144
20153
20163
20174
20191
20202
20221

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed72

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
National Cancer Institute (NCI)13
Dana-Farber Cancer Institute3
Eisai Inc.3
Genzyme, a Sanofi Company3
Amgen2
Bayer2
Kenneth Ain2
Memorial Sloan Kettering Cancer Center2
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)2
Pfizer2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Thyroid Neoplasms72
Thyroid Cancer, Papillary21
Adenocarcinoma, Follicular19
Carcinoma, Medullary15
Head and Neck Neoplasms11
Thyroid Carcinoma, Anaplastic9
Carcinoma, Non-Small-Cell Lung5
Lung Neoplasms4
Melanoma3
Neoplasms3

Trials

Showing 1 to 25 of 72. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.